Deep Dutta
| Deep Dutta | |
|---|---|
| Born | |
| 🎓 Alma mater |
|
| 💼 Occupation | |
| Known for | Systematic reviews and meta-analyses in diabetes and obesity pharmacotherapy |
| 🏅 Awards |
|
Deep Dutta is an Indian endocrinologist and clinical researcher based in New Delhi. He is director of the department of endocrinology and metabolism at CEDAR Superspeciality Healthcare in Dwarka, New Delhi, and formerly served as an assistant professor of endocrinology at PGIMER and Dr. Ram Manohar Lohia Hospital, New Delhi.[1] His research focuses on the pharmacotherapy of type 2 diabetes, obesity and other endocrine and metabolic disorders, much of it published as systematic reviews and meta-analyses.[1][2]
Early life and education
Dutta received his Bachelor of Medicine, Bachelor of Surgery (MBBS) from the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, in 2006, where he was awarded a gold medal in community medicine. He completed a Doctor of Medicine (MD) in internal medicine at Calcutta Medical College in 2009, and a Doctorate of Medicine (DM) in endocrinology at the Institute of Postgraduate Medical Education and Research (IPGMER) and SSKM Hospital, Kolkata, in 2013. He obtained a Diplomate of National Board (DNB) in endocrinology in 2014.[1]
Career
After his postgraduate training, Dutta worked as a senior resident in endocrinology at Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi (2009–2010), and subsequently as a post-doctoral research fellow at IPGMER and SSKM Hospital, Kolkata. From 2014 to 2016 he was an assistant professor in the department of endocrinology at PGIMER and Dr. Ram Manohar Lohia Hospital, New Delhi, where he was also involved in institutional ethics and thesis review committees. He then served as senior consultant and head of endocrinology, diabetes and metabolism at Venkateshwar Hospital, Dwarka (2016–2019), before establishing his practice at CEDAR Superspeciality Healthcare.[1]
He is a Fellow of the Royal College of Physicians of Edinburgh (FRCP, 2019) and a Fellow of the American College of Endocrinology (FACE, 2016), and holds the Specialty Certificate in Endocrinology and Diabetes awarded by the Federation of the Royal Colleges of Physicians of the United Kingdom (2015).[1]
Research
Dutta's published work spans the pharmacological management of diabetes and obesity, bone and mineral metabolism, thyroid disorders, and endocrine aspects of HIV infection. A large share comprises systematic reviews and meta-analyses evaluating newer drug classes, including GLP-1 receptor agonists, SGLT2 inhibitors, tirzepatide and related incretin-based therapies, and lipid-lowering and antidiabetic agents.[2] His earlier clinical research, conducted in eastern India, examined prediabetes progression, vitamin D supplementation and inflammatory markers in insulin resistance.[3]
His work appears in journals including Diabetes, Obesity and Metabolism, The Lancet Diabetes & Endocrinology, The Journal of Clinical Endocrinology and Metabolism, Diabetes Care, Endocrine Practice and the Indian Journal of Endocrinology and Metabolism.[2] As of 2026 he has more than 250 articles indexed in PubMed;[2] his Google Scholar profile reports an h-index of 37 and over 6,000 citations.[1]
Awards and honours
- Anil R. Seth Award for best clinical research in endocrinology, Endocrine Society of India (2016)[1]
- RSSDI Young Investigator Award, Research Society for the Study of Diabetes in India (2016)[1]
Selected publications
- Dutta, D; Mukhopadhyay, S (2018). "Novel diabetes subgroups". The Lancet Diabetes & Endocrinology. 6 (6): 438. doi:10.1016/S2213-8587(18)30129-3. PMID 29803261.
- Dutta, D; et al. (2014). "Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation". Diabetes Research and Clinical Practice. 103 (3): e18–23. PMID 24456991.
- Dutta, D; et al. (2021). "Efficacy and safety of novel twincretin tirzepatide... in the management of type-2 diabetes: A Cochrane meta-analysis". Indian Journal of Endocrinology and Metabolism. 25 (6): 475–489. doi:10.4103/ijem.ijem_423_21. PMID 35355921 Check
|pmid=value (help). - Bhattacharya, S; Nagendra, L; Dutta, D; Kamrul-Hasan, ABM (2025). "Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials". The Journal of Clinical Endocrinology and Metabolism. 110 (6): 1781–1791. doi:10.1210/clinem/dgae878. PMID 39689014 Check
|pmid=value (help). - Dutta, D; et al. (2025). "Efficacy and safety of the glucagon receptor antagonist volagidemab in type-1 diabetes: A systematic review and meta-analysis". Annals of the New York Academy of Sciences. 1543 (1): 94–101. doi:10.1111/nyas.15262. PMID 39625039 Check
|pmid=value (help). - De, BK; Dutta, D; et al. (2010). "Role of garlic in hepatopulmonary syndrome: A randomized controlled trial". Canadian Journal of Gastroenterology. 24 (3): 183–188. PMID 20352147.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 "Deep Dutta". Google Scholar. Retrieved 28 June 2026.
- ↑ 2.0 2.1 2.2 2.3 "Deep Dutta — author search results". PubMed. National Library of Medicine. Retrieved 28 June 2026.
- ↑ Dutta, D; et al. (2014). "Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes". Diabetes Research and Clinical Practice. 103 (3): e18–23. PMID 24456991.
External links
- "Deep Dutta — bibliography". National Center for Biotechnology Information.
- "Deep Dutta". Google Scholar.
This article "Deep Dutta" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Deep Dutta. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
